These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29204127)

  • 1. Synthetic Aminoindanes: A Summary of Existing Knowledge.
    Pinterova N; Horsley RR; Palenicek T
    Front Psychiatry; 2017; 8():236. PubMed ID: 29204127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aminoindanes--the next wave of 'legal highs'?
    Sainsbury PD; Kicman AT; Archer RP; King LA; Braithwaite RA
    Drug Test Anal; 2011; 3(7-8):479-82. PubMed ID: 21748859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gas chromatography-mass spectrometry of eight aminoindanes: 2-Aminoindane, N-methyl-2-, 5-methoxy-, 5-methoxy-6-methyl-, 4,5-methylenedioxy-, 5,6-methylenedioxy- and 5-iodo-2-aminoindane, and rasagiline.
    Rose AR; Staretz ME; Joshi M; Wood M; Brettell TA
    Rapid Commun Mass Spectrom; 2021; 35(24):e9207. PubMed ID: 34599535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5,6-Methylenedioxy-2-aminoindane: from laboratory curiosity to 'legal high'.
    Gallagher CT; Assi S; Stair JL; Fergus S; Corazza O; Corkery JM; Schifano F
    Hum Psychopharmacol; 2012 Mar; 27(2):106-12. PubMed ID: 22389075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study on the metabolism of 5,6-methylenedioxy-2-aminoindane (MDAI) in rats: identification of urinary metabolites.
    Židková M; Linhart I; Balíková M; Himl M; Váňa L; Vetýška M; Páleníček T; Lhotková E; Dušek M
    Xenobiotica; 2017 Jun; 47(6):505-514. PubMed ID: 27401914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological profiles of aminoindanes, piperazines, and pipradrol derivatives.
    Simmler LD; Rickli A; Schramm Y; Hoener MC; Liechti ME
    Biochem Pharmacol; 2014 Mar; 88(2):237-44. PubMed ID: 24486525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MDAI (5,6-methylenedioxy-2-aminoindane; 6,7-dihydro-5H-cyclopenta[f][1,3]benzodioxol-6-amine; 'sparkle'; 'mindy') toxicity: a brief overview and update.
    Corkery JM; Elliott S; Schifano F; Corazza O; Ghodse AH
    Hum Psychopharmacol; 2013 Jul; 28(4):345-55. PubMed ID: 23881883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral and Pharmacokinetics Studies of
    Tirri M; Corli G; Arfè R; Marchetti B; Bilel S; Bernardi T; Boccuto F; Odoardi S; Mestria S; Strano-Rossi S; Marti M
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging toxicity of 5,6-methylenedioxy-2-aminoindane (MDAI): Pharmacokinetics, behaviour, thermoregulation and LD50 in rats.
    Páleníček T; Lhotková E; Žídková M; Balíková M; Kuchař M; Himl M; Mikšátková P; Čegan M; Valeš K; Tylš F; Horsley RR
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Aug; 69():49-59. PubMed ID: 27083855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological profile of mephedrone analogs and related new psychoactive substances.
    Luethi D; Kolaczynska KE; Docci L; Krähenbühl S; Hoener MC; Liechti ME
    Neuropharmacology; 2018 May; 134(Pt A):4-12. PubMed ID: 28755886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The metabolic fate of two new psychoactive substances - 2-aminoindane and N-methyl-2-aminoindane - studied in vitro and in vivo to support drug testing.
    Manier SK; Felske C; Eckstein N; Meyer MR
    Drug Test Anal; 2020 Jan; 12(1):145-151. PubMed ID: 31667988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the anorectic and motor activity effects of some aminoindanes, 2-aminotetralin and amphetamine in the rat.
    Mrongovius RI; Bolt AG; Hellyer RO
    Clin Exp Pharmacol Physiol; 1978; 5(6):635-40. PubMed ID: 719961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects and risks associated to mephedrone and methylone in humans: A review of the preliminary evidences.
    Karila L; Billieux J; Benyamina A; Lançon C; Cottencin O
    Brain Res Bull; 2016 Sep; 126(Pt 1):61-67. PubMed ID: 26995278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signaling.
    Liechti M
    Swiss Med Wkly; 2015; 145():w14043. PubMed ID: 25588018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic cathinones: an evolving class of new psychoactive substances.
    Gonçalves JL; Alves VL; Aguiar J; Teixeira HM; Câmara JS
    Crit Rev Toxicol; 2019 Aug; 49(7):549-566. PubMed ID: 31747318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Pharmacology of the Synthetic Cathinone Mephedrone.
    Papaseit E; Moltó J; Muga R; Torrens M; de la Torre R; Farré M
    Curr Top Behav Neurosci; 2017; 32():313-331. PubMed ID: 28012094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-Activity Relationships of Substituted Cathinones, with Transporter Binding, Uptake, and Release.
    Eshleman AJ; Wolfrum KM; Reed JF; Kim SO; Swanson T; Johnson RA; Janowsky A
    J Pharmacol Exp Ther; 2017 Jan; 360(1):33-47. PubMed ID: 27799294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic cannabinoid receptor agonists: classification and nomenclature.
    Potts AJ; Cano C; Thomas SHL; Hill SL
    Clin Toxicol (Phila); 2020 Feb; 58(2):82-98. PubMed ID: 31524007
    [No Abstract]   [Full Text] [Related]  

  • 19. Keeping pace with NPS releases: fast GC-MS screening of legal high products.
    Elie MP; Elie LE; Baron MG
    Drug Test Anal; 2013 May; 5(5):281-90. PubMed ID: 23297247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic cathinones: a new public health problem.
    Karila L; Megarbane B; Cottencin O; Lejoyeux M
    Curr Neuropharmacol; 2015 Jan; 13(1):12-20. PubMed ID: 26074740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.